期刊文献+

透析对尿毒症患者凝血系统的影响 被引量:4

Changes of Coagulationary System of Patients with Uremia in Hemodialysis and Peritoneal Dial
下载PDF
导出
摘要 目的观察尿毒症透析前患者组、血透(HD)组、腹透(CAPD)组凝血、纤溶功能的变化。方法采用ELISA法检测患者血浆TAT、D-二聚体水平,同时检测患者常规凝血项目(PT、APTT、TT、Fbg)。结果尿毒症患者透析前后TAT、D-二聚体水平均升高,以CAPD组升高尤为明显,患者透析前TT、APTT缩短,透析后APTT情况有所好转。结论尿毒症患者体内存在高凝继发高纤的状态,透析尤其是腹膜透析可加剧这种紊乱。TAT、D-二聚体的测定较常规凝血检查能更准确反映患者体内凝血、纤溶状态。 Objective To investigate coagulation and fibrinolysis on haemodialysis (HD),continuous ambulatory peritoneal dialysis(CAPD) and uremia patients. Methods TAT,D-dimer were measured by ELISA. Results The plasma level of TAT,D-dimer were significant in HD,CAPD,uremia patients,they were most significant in CAPD patients. TT, APTT were significantly shortened in patients. Conclusion There are turbulence of coagulation and fibrinolysis in all patients,the prothrombotic state in CAPD patients are most sever in contrast with uremia and HD patients. The plasma of TAT,D-dimer are more significant than TT,APTT to reflect the state of patients.
作者 朱梅俪 茅挺
出处 《临床输血与检验》 CAS 2009年第4期301-303,共3页 Journal of Clinical Transfusion and Laboratory Medicine
关键词 尿毒症 凝血 纤溶 凝血酶-抗凝血酶Ⅲ复合物 D-二聚体 Uremia Coagulation Fibrinolysis ATA D-dimer
  • 相关文献

参考文献7

  • 1Eberst ME,Berkowitz LR. Hemostasis in renal disease: pathophysiology and management[J]. Am J Med, 1994, 96(2) : 168-179.
  • 2Vukovich TC,Hamwi A,Bieglmayer C. D-dimer testing within the routine clinical chemistry profile [J]. Clin Chem, 1998,44 (7) : 1557-1558.
  • 3Eichinger S, Minar E,Bialonezyk C. D-dimer levels and risk of recurrent venous thromboembolism[J]. AMA, 2003,290 (9) : 1071-1077.
  • 4Inoue A, Wada H, Takagi M, et al. Hemostatic abnorealities in patients with thrombotic comlication on maintenance hemodialysis [J]. Clin APPL Thromb Hemost, 2000,6 (2) : 100-103.
  • 5Malyszo J, Malyszko JS, Mysliwiec M, et al. Comparison of hemostatic disturbance on between patients on CAPD and patients on hemodialysis[J]. Perit Dial Int, 2001,21 (2) : 158-165.
  • 6谢忠明,李艳,张雄,李发香.血液透析和肾移植对慢性肾功能衰竭患者血液流变性的影响[J].微循环学杂志,1999,9(2):52-53. 被引量:2
  • 7蔡小燕,潘学谊,黄华,张柔玲.尿毒症患者血浆凝血因子的变化及其临床意义[J].血栓与止血学,2006,12(2):70-72. 被引量:8

二级参考文献11

  • 1刘惠 邹成钢 等.尿毒症患者RBC结构和功能的改变及其意义[J].中华肾脏病杂志,1998,14(4):270-270.
  • 2[3]KRAAIJENHAGEN RA,ANKER PS,KOOPMAN MM,et al.High plasma cocentration factor Ⅷ:C is a major risk factor for venous thromboembolism[J].Thromb Haemost,2000,83:5-9.
  • 3[4]KARIO K,MATSUO T,MIYATA T.Activated factor Ⅶ as new cardiovascular risk factor of atherothrombotic disease[J],Rinsho Byori,1995,43:1201-1208.
  • 4[5]KRAAIJENHAGEN RA,ANKER PS,KOOPMAN MMW,et al.High plasma concentration of factor Ⅷ:C is a major risk factor for venous[J].Thromb Haemost,2000,83:5-9.
  • 5邱建新,中华器官移植杂志,1998年,19卷,3期,172页
  • 6刘惠,中华肾脏病杂志,1998年,14卷,4期,270页
  • 7翁维良,血液流变学研究方法及其应用,1989年,185页
  • 8孙雪峰,周希静.维持性血液透析患者内瘘阻塞因素的探讨[J].中华肾脏病杂志,1998,14(1):51-51. 被引量:35
  • 9邱建新,谢桐,王祥慧,徐达.肾移植后红细胞增多症的药物治疗[J].中华器官移植杂志,1998,19(3):174-174. 被引量:4
  • 10方峻.尿毒症高凝状态与凝血因子Ⅶ[J].国外医学(输血及血液学分册),1999,22(3):157-159. 被引量:5

共引文献8

同被引文献41

引证文献4

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部